The highest dose (400 mg/kg) demonstrated the strongest anti‐inflammatory effect, restoring CRP and ALP levels closer to those of the control group and the reference laxative (YOH, 2 mg/kg, b.w.), further supporting its potential in alleviating LOP‐induced intestinal inflammation (Table 4). The gene discussed is CRP; the disease is inflammatory response.